Walsh Sophie, Choi Eunhee, Fang Chloe, Narita Keisuke, Cepeda Maria, Frangaj Brulinda, Kim Sofia, Mercado Yaniris, Nesheim-Case Riley, Ramirez Uriel Alvira, Barrett Matthew, Schwartz Joseph E, Shimbo Daichi
The Columbia Hypertension Center and Lab, Columbia University Irving Medical Center, New York, New York, USA.
Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center, New York, New York, USA.
Am J Hypertens. 2025 Apr 15;38(5):288-294. doi: 10.1093/ajh/hpaf017.
The 2017 American College of Cardiology (ACC)/American Heart Association (AHA) BP guideline recommends ambulatory BP monitoring (ABPM) for diagnosing masked hypertension among adults not taking antihypertensive medication with borderline office BP (i.e., office systolic BP [SBP] 120 to < 130 mm Hg or diastolic BP [DBP] 75 to < 80 mm Hg).
Using data from the Improving the Detection of Hypertension Study, sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and likelihood ratios for a positive and negative test of having borderline office BP (i.e., office SBP 120 to < 130 mm Hg or DBP 75 to < 80 mm Hg) for diagnosing masked hypertension (i.e., mean awake SBP ≥ 130 mm Hg or mean awake DBP ≥ 80 mm Hg) were determined among 263 participants who had a mean office SBP < 130 mm Hg and mean DBP < 80 mm Hg. Likelihood ratios for a positive test > 10, 5-10, and < 5 were considered strong, moderate, and weak, respectively. Likelihood ratios for a negative test < 0.1, 0.1-0.2, and > 0.2 were considered strong, moderate, and weak, respectively.
Among the 263 participants, mean ± SD age was 39.2 ± 12.8 years, 62.4% were female, 38.4% had borderline office BP, and 26.2% had masked hypertension. SN, SP, PPV, and NPV were 0.754, 0.747, 0.515, and 0.895, respectively. The likelihood ratios for a positive and negative test were 2.984 (weak) and 0.330 (weak), respectively.
The use of borderline office BP thresholds recommended in the 2017 ACC/AHA BP guideline did not sufficiently rule in or rule out masked hypertension.
2017年美国心脏病学会(ACC)/美国心脏协会(AHA)血压指南建议,对于未服用降压药物且诊室血压处于临界值(即诊室收缩压[SBP]120至<130 mmHg或舒张压[DBP]75至<80 mmHg)的成年人,采用动态血压监测(ABPM)来诊断隐匿性高血压。
利用改善高血压检测研究中的数据,在263名诊室平均SBP<130 mmHg且平均DBP<80 mmHg的参与者中,确定以临界诊室血压(即诊室SBP 120至<130 mmHg或DBP 75至<80 mmHg)进行隐匿性高血压(即清醒时平均SBP≥130 mmHg或清醒时平均DBP≥80 mmHg)诊断的灵敏度(SN)、特异度(SP)、阳性预测值(PPV)、阴性预测值(NPV)以及阳性和阴性检验似然比。阳性检验似然比>10、5 - 10和<5分别被视为强、中、弱。阴性检验似然比<0.1、0.1 - 0.2和>0.2分别被视为强、中、弱。
在263名参与者中,平均年龄±标准差为39.2±12.8岁,62.4%为女性,38.4%有临界诊室血压,26.2%有隐匿性高血压。SN、SP、PPV和NPV分别为0.754、0.747、0.515和0.895。阳性和阴性检验似然比分别为2.984(弱)和0.330(弱)。
采用2017年ACC/AHA血压指南中推荐的临界诊室血压阈值,对隐匿性高血压的诊断或排除作用不充分。